Obstetrics & Gynecology Doctors in Elyria, OH Accepting Medicare

9 Obstetrics & Gynecology doctors found. Showing 1 - 9

Liengkong Siew, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 507 E River, Elyria, OH 44035 Phone: 440-323-5055    Fax: 440-323-0759

Dr. Usha Gupta, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 630 E River St, Elyria, OH 44035 Phone: 440-781-1943

Dr. I. Cletus M. Fernando, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 630 E River St, Elyria, OH 44035 Phone: 440-329-7500

Dr. Michael V. Koroly, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 630 E River St, Elyria, OH 44035 Phone: 440-329-7500

Tammy J Nemeth, APRN.CNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 303 Chestnut Commons Dr, Elyria, OH 44035 Phone: 440-366-9444

Michele D Lowe, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 125 E Broad St Ste 218, Elyria, OH 44035 Phone: 440-329-7310    Fax: 440-329-7749

Dr. Ramiz Masri, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 125 E Broad St, Suite 218, Elyria, OH 44035 Phone: 440-329-7310    Fax: 440-329-7749

Dr. Meir Benit, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 661 E River St, Suite A, Elyria, OH 44035 Phone: 440-325-4155    Fax: 440-323-6860

Kevin E Wisler, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 125 E Broad St, Suite 302, Elyria, OH 44035 Phone: 440-329-7330    Fax: 440-329-7335

News Archive

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.

Aastrom Biosciences and ATEK Medical enter new strategic partnership

Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, and ATEK Medical, a leading medical device manufacturer, today announced the formation of a new strategic partnership in which ATEK Medical will supply key components and technology for use in Aastrom's proprietary cell manufacturing process.

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Johnson & Johnson and Crucell N.V. today announced that they are in advanced negotiations for a potential public offer by Johnson & Johnson or an affiliate for all outstanding ordinary shares of Crucell not already held by Johnson & Johnson and its affiliates.

Post-COVID depressive symptoms respond well to antidepressants, study shows

The COVID pandemic has led to a significant increase in mental health problems. Now, in some good news, a pilot study has shown that depressed patients who have suffered from COVID respond better to standard antidepressants than do people who have not had COVID.

Third-quarter fiscal 2009 results announced by Urodynamix Technologies

Urodynamix Technologies Ltd. today reported its financial results for its fiscal third quarter ended September 30, 2009. The Company reported a loss of $638,287 or $0.01 per share basic and diluted compared to a loss of $737,341or $0.01, basic and diluted, for the comparative quarter of the prior year. Revenue for the quarter ended September 30, 2009 at $15,285, decreased 55% over the same quarter of the prior year.

Read more Medical News

› Verified 4 days ago